局限性胎盘嵌合与妊娠结局及胎儿生长关系的文献综述
本综述检索截至2020年7月16日的多个数据库,纳入70篇文献共328例胎儿,评估局限性胎盘嵌合(CPM)与胎儿生长受限(FGR)及不良妊娠结局的关联。结果显示CPM病例中FGR报告率71.7%、早产(<37周)31.0%、结构畸形24.2%,建议对CPM妊娠从早孕期开始密切监测胎儿生长。
要点
- CPM病例中FGR报告率71.7%,早产(<37周)31.0%,结构畸形24.2%。
- 涉及2、3、7、13、15、16和22号染色体的CPM证据充分,出生体重常低于第5百分位。
- 建议CPM妊娠从早孕期开始密切监测胎儿生长并详细排查结构畸形。
核心结论
- CPM与胎儿生长受限、早产及结构畸形风险升高相关,尤其涉及2、3、7、13、15、16和22号染色体时证据充分。
- 绒毛膜绒毛取样中高比例嵌合及单亲二体(UPD)与不良妊娠结局显著相关。
研究设计与样本
- 文献综述,检索Embase、PubMed、Medline Ovid、Web of Science、Cochrane CENTRAL及Google Scholar截至2020年7月16日的文献。
- 最终纳入70篇文献,分析328例胎儿。
主要发现
- CPM病例中FGR报告率为71.7%,早产(<37周)报告率为31.0%。
- CPM病例中结构胎儿畸形率为24.2%。
- 8种染色体(共分析14种)的CPM有充分证据显示出生体重常低于胎儿生长标准第5百分位。
- 绒毛膜绒毛取样高比例嵌合及UPD与不良妊娠结局显著相关。
关键数值与推荐
- CPM涉及2、3、7、13、15、16和22号染色体时,出生体重常低于第5百分位,证据充分。
- FGR报告率71.7%,早产(<37周)31.0%,结构畸形24.2%。
临床怎么用
- CPM妊娠应从早孕期开始密切监测胎儿生长。
- 对CPM胎儿应详细排查结构畸形,并警惕早产(可能为极早产)风险。
- 尽管近五分之一病例早产,CPM活产儿的长期随访似乎良好。
局限性
- 文献中关于CPM与FGR及其他妊娠结局的关联存在矛盾证据。
- 嵌合体的准确诊断在技术上仍具挑战性,胚胎内异常细胞的命运 largely 未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chromosomal mosaicism can be detected in different stages of early life: in cleavage stage embryos, in blastocysts and biopsied cells from blastocysts during preimplantation genetic testing for aneuploidies (PGT-A) and later during prenatal testing, as well as after birth in cord blood. Mosaicism at all different stages can be associated with adverse pregnancy outcomes. There is an onward discussion about whether blastocysts diagnosed as chromosomally mosaic by PGT-A should be considered safe for transfer. An accurate diagnosis of mosaicism remains technically challenging and the fate of abnormal cells within an embryo remains largely unknown. However, if aneuploid cells persist in the extraembryonic tissues, they can give rise to confined placental mosaicism (CPM). Non-invasive prenatal testing (NIPT) uses cell-free (cf) DNA released from the placenta in maternal blood, facilitating the detection of CPM. In literature, conflicting evidence is found about whether CPM is associated with fetal growth restriction (FGR) and/or other pregnancy outcomes. This makes counselling for patients by clinicians challenging and more knowledge is needed for clinical decision and policy making. OBJECTIVE AND RATIONALE: The objective of this review is to evaluate the association between CPM and prenatal growth and adverse pregnancy outcomes. All relevant literature has been reviewed in order to achieve an overview on merged results exploring the relation between CPM and FGR and other adverse pregnancy outcomes. SEARCH METHODS: The following Medical Subject Headings (MESH) terms and all their synonyms were used: placental, trophoblast, cytotrophoblast, mosaicism, trisomy, fetal growth, birth weight, small for gestational age and fetal development. A search in Embase, PubMed, Medline Ovid, Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL) and Google Scholar databases was conducted. Relevant articles published until 16 July 2020 were critically analyzed and discussed. OUTCOMES: There were 823 articles found and screened based on their title/abstract. From these, 213 articles were selected and full text versions were obtained for a second selection, after which 70 publications were included and 328 cases (fetuses) were analyzed. For CPM in eight different chromosomes (of the total 14 analyzed), there was sufficient evidence that birth weight was often below the 5th percentile of fetal growth standards. FGR was reported in 71.7% of CPM cases and preterm birth (<37 weeks of delivery) was reported in 31.0% of cases. A high rate of structural fetal anomalies, 24.2%, in cases with CPM was also identified. High levels of mosaicism in CVS and presence of uniparental disomy (UPD) were significantly associated with adverse pregnancy outcomes. WIDER IMPLICATIONS: Based on the literature, the advice to clinicians is to monitor fetal growth intensively from first trimester onwards in case of CPM, especially when chromosome 2, 3, 7, 13, 15, 16 and 22 are involved. In addition to this, it is advised to examine the fetuses thoroughly for structural fetal anomalies and raise awareness of a higher chance of (possibly extreme) premature birth. Despite prematurity in nearly a fifth of cases, the long-term follow-up of CPM life borns seems to be positive. More understanding of the biological mechanisms behind CPM will help in prioritizing embryos for transfer after the detection of mosaicism in embryos through PGT-A.
引用
- Eggenhuizen GM, Go A, Koster MPH, et al. Confined placental mosaicism and the association with pregnancy outcome and fetal growth: a review of the literature. Hum Reprod Update. 2021. PMID: 33984128. doi:10.1093/humupd/dmab009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。